Travere Therapeutics to Present at Upcoming Investor Conferences
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in two upcoming investor conferences in August 2024. The company will present at the 2024 Wedbush PacGrow Healthcare Conference on Tuesday, August 13, at 2:30 p.m. ET, and the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, at 12:30 p.m. ET.
A live webcast of the Canaccord Genuity conference presentation will be available on Travere's website investor page, with a replay accessible for up to 30 days after the event. This announcement highlights Travere's commitment to engaging with investors and sharing company updates through these important industry events.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato la sua partecipazione a due prossime conferenze per investitori ad agosto 2024. La società presenterà alla 2024 Wedbush PacGrow Healthcare Conference martedì 13 agosto, alle 14:30 ET, e alla Canaccord Genuity 44ª Conferenza Annuale sulla Crescita mercoledì 14 agosto, alle 12:30 ET.
Una trasmissione in diretta della presentazione alla conferenza Canaccord Genuity sarà disponibile sulla pagina per investitori del sito web di Travere, con una registrazione accessibile per un massimo di 30 giorni dopo l'evento. Questo annuncio evidenzia l'impegno di Travere a interagire con gli investitori e a condividere aggiornamenti aziendali attraverso questi importanti eventi del settore.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado su participación en dos próximas conferencias para inversores en agosto de 2024. La compañía presentará en la 2024 Wedbush PacGrow Healthcare Conference el martes 13 de agosto a las 2:30 p.m. ET, y en la Canaccord Genuity 44ª Conferencia Anual de Crecimiento el miércoles 14 de agosto a las 12:30 p.m. ET.
Una transmisión en vivo de la presentación en la conferencia Canaccord Genuity estará disponible en la página de inversores del sitio web de Travere, con una repetición accesible durante 30 días después del evento. Este anuncio resalta el compromiso de Travere de interactuar con los inversores y compartir actualizaciones de la empresa a través de estos importantes eventos de la industria.
Travere Therapeutics (NASDAQ: TVTX)가 2024년 8월에 있을 두 개의 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사는 8월 13일 화요일 오후 2:30 ET에 2024 Wedbush PacGrow Healthcare Conference에서 발표하고, 8월 14일 수요일 오후 12:30 ET에 Canaccord Genuity 제44회 연례 성장 컨퍼런스에 참석할 예정입니다.
Canaccord Genuity 컨퍼런스 발표의 실시간 웹 중계는 Travere의 투자자 페이지에서 확인할 수 있으며, 이벤트 후 30일 동안 재생할 수 있습니다. 이번 발표는 Travere가 투자자와 소통하고 중요한 산업 행사에서 회사 업데이트를 공유하려는 의지를 강조합니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé sa participation à deux prochaines conférences pour investisseurs en août 2024. La société présentera à la 2024 Wedbush PacGrow Healthcare Conference le mardi 13 août à 14h30 ET, et à la Canaccord Genuity 44e Conférence Annuelle sur la Croissance le mercredi 14 août à 12h30 ET.
Un webcast en direct de la présentation à la conférence Canaccord Genuity sera disponible sur la page des investisseurs du site de Travere, avec un replay accessible jusqu'à 30 jours après l'événement. Cette annonce souligne l'engagement de Travere à interagir avec les investisseurs et à partager des mises à jour sur l'entreprise lors de ces événements importants dans l'industrie.
Travere Therapeutics (NASDAQ: TVTX) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im August 2024 bekannt gegeben. Das Unternehmen wird am Dienstag, den 13. August, um 14:30 Uhr ET auf der 2024 Wedbush PacGrow Healthcare Conference präsentieren und am Mittwoch, den 14. August, um 12:30 Uhr ET auf der Canaccord Genuity 44. jährlichen Wachstums-Konferenz.
Eine Live-Übertragung der Präsentation der Canaccord Genuity-Konferenz wird auf der Investorenseite von Travere auf der Webseite verfügbar sein, mit einem Replay, das bis zu 30 Tage nach der Veranstaltung zugänglich ist. Diese Ankündigung hebt das Engagement von Travere hervor, mit Investoren in Kontakt zu treten und Unternehmensaktualisierungen durch diese wichtigen Branchenveranstaltungen zu teilen.
- None.
- None.
SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in August:
2024 Wedbush PacGrow Healthcare Conference
Tuesday, August 13, 2024, at 2:30 p.m. ET
Canaccord Genuity 44th Annual Growth Conference
Wednesday, August 14, 2024, at 12:30 p.m. ET
A live webcast of the Canaccord Genuity 44th Annual Growth Conference presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and a replay will be available for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact:
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
FAQ
When is Travere Therapeutics (TVTX) presenting at the 2024 Wedbush PacGrow Healthcare Conference?
What time is Travere Therapeutics (TVTX) scheduled to present at the Canaccord Genuity 44th Annual Growth Conference?
Where can investors access the webcast of Travere Therapeutics' (TVTX) presentation at the Canaccord Genuity conference?
How long will the replay of Travere Therapeutics' (TVTX) Canaccord Genuity conference presentation be available?
